elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36624746-0A179E6C-906D-46AD-93D2-3DD65EB46416
Q36624746-0A179E6C-906D-46AD-93D2-3DD65EB46416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36624746-0A179E6C-906D-46AD-93D2-3DD65EB46416
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up.
P2860
Q36624746-0A179E6C-906D-46AD-93D2-3DD65EB46416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36624746-0A179E6C-906D-46AD-93D2-3DD65EB46416
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f0dd8d66d07e1595a5298573574e8a94a7ebdc3
P2860
Fabry disease: dose matters.